HOLZ rings in EBSD patterns of the UFeB4 compound: association with a random distribution of planar defects.

The UFeB4 phase present in different alloys of the B-Fe-U system was studied by powder X-ray diffraction (PXRD) and scanning electron microscopy complemented with energy-dispersive spectroscopy and electron backscattered diffraction (EBSD). The PXRD data showed that the ternary compound crystallized adopting essentially the YCrB4-type structure. However, microstructural observations revealed that under high undercooling conditions the UFeB4 phase exhibits a random distribution of defects parallel to, which are consistently associated with intense higher-order Laue zone rings in EBSD patterns. Indexation of the EBSD patterns showed that the defective structure is compatible with an intergrowth of YCrB4- and ThMoB4-type layers according to the (010)(YCrB4)//(110)(ThMoB4) and [001]YCrB4//[001](ThMoB4) orientation relation previously reported for an analogous compound. Magnetic studies indicated that the annealed UFeB4 compound has a paramagnetic behavior in the 2-300 K temperature range.

Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies.

A series of four Pt(II) complexes anchored by bidentate or tridentate pyrazolyl-alkylamine chelators bearing different substituents at the azolyl rings has been prepared with the aim to assess their interest in the design of novel anticancer drugs. All complexes have been fully characterized by classical analytical methods and three of them were characterized also by X-ray diffraction analysis. Their solution behavior, together with lipophilicity measurements, cell uptake, antiproliferative properties, DNA interaction have been evaluated. Albeit all the complexes were less active than cisplatin on ovarian carcinoma A2780 cell line, greatly retained their activity in the cisplatin-resistant A2780cisR cell line and presented a lower resistance factor compared to cisplatin. Moreover, the Pt(II) complexes under investigation were less prone to undergo deactivation by glutathione, believed to be the major cellular target of cisplatin that inactivates the drug by binding to it irreversibly.

The uranium-nitrogen bond in U IV complexes supported by the hydrotris(3,5-dimethylpyrazolyl)borate ligand.

Insertion of benzonitrile and acetonitrile into the U-C bond of [U(Tp(Me2))Cl(2)(CH(2)SiMe(3))](Tp(Me2)= HB(3,5-Me(2)pz)(3)) gives the ketimide complexes [U(Tp(Me2))Cl(2){NC(R)(CH(2)SiMe(3))}](R = Ph (1); Me (2)). The identity of complex was ascertained by a single-crystal X-ray diffraction study. In the solid state exhibits octahedral geometry with a short U-N bond length to the ketimide ligand. We also report herein the synthesis and the X-ray crystal structures of the uranium amide complexes [U(Tp(Me2))Cl(2)(NR(2))](R = Et (3); Ph (4)). A detailed comparison of the U-N bond lengths in these compounds with other known U-N (and Th-N) distances in amide and ketimide actinide(IV) complexes is performed, confirming the short character of the U-N bond length in 1.